利索-全球专利检索

  1. 登录
  2. 注册
发明公开
KR20210030405A ILT4에 결합하는 항체 审中-公开

  • 专利标题： ILT4에 결합하는 항체
  • 专利标题（英）： KR20210030405A - Antibodies that bind to ILT4
  • 申请号： KR20217003581
    申请日： 2019-07-08
  • 公开(公告)号： KR20210030405A
    公开(公告)日： 2021-03-17
  • 优先权： US201862695600 2018-07-09; US201862744611 2018-10-11
  • 主分类号： C07K16/28
  • IPC分类号： C07K16/28 ;  A61K39/00 ;  A61K47/68 ;  A61P35/00
ILT4에 결합하는 항체
摘要：
본출원은 LILRB2, LIR2, MIR10, 및 CD85d로도공지된이뮤노글로불린-유사전사체 4 (ILT4)에특이적으로결합하는항체, 및상응하는핵산, 숙주세포, 조성물및 용도에관한것이다. 일부실시양태에서, 항체는인간 ILT4에특이적으로결합하지만, ILT2, ILT3, 또는 ILT5, 또는 LILRA 또는 LILRB 패밀리의다른구성원에는유의하게결합하지않는다.
摘要（英）：

This application relates to antibodies that specifically bind to immunoglobulin-like transcript 4 (ILT4), also known as LILRB2, LIR2, MIR10, and CD85d, and the corresponding nucleic acids, host cells, compositions and uses. In some embodiments, the antibody specifically binds human ILT4, but does not significantly bind ILT2, ILT3, or ILT5, or other members of the LILRA or LILRB family.

信息查询
Espacenet
0/0